SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Lillys ESMO update on investigational ovarian-cancer drug Sofe-M with bevacizumab is drawing attention, with traders citing encouraging early response and disease-control results as evidence of pipeline growth beyond obesity drugs. The discussion also weighs the shares pullback against optimism and caution ahead of the quarterly report.

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

BioNTech and Bristol Myers Squibbs Phase 2 pumitamig-plus-docetaxel results in advanced NSCLC are drawing attention, with traders focused on the response and progression-free-survival signal after prior immunotherapy and chemotherapy. The main question is whether the benefit will prove durable in later analyses.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ousters planned integration of its Rev8 lidar into John Deere subsidiary GUSS Automations next-generation autonomous orchard machines, alongside other deployment and partnership updates, is fueling discussion of its Physical AI growth prospects. Traders remain divided: some see these applications as evidence of commercial traction, while others focus on the volatile share-price decline, valuation and path to profitability amid pressure on growth stocks.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Positive prostate cancer trial updatesespecially results showing lower recurrence risk with ERLEADAare driving attention, with traders watching whether buyers support the shares after the news. Some see the pullback as a pause with room for follow-through, while others question whether the results are already priced in.

Kratos Defense & Security Solutions, Inc. engages in the provision of mission critical products, services and solutions for United States national security priorities. It operates through the Kratos Government Solutions (KGS) and Unmanned Systems (US) segments. The KGS segment consists of an aggregation of KGS operating segments, including microwave electronic products, space, satellite and cyber, training solutions. The US segment refers to the unmanned aerial, unmanned ground, unmanned seaborne and related command, control and communications system businesses. The company was founded on December 19, 1994, and is headquartered in Round Rock, TX.

Kratos Defense & Security Solutions Inc

Kratos is drawing attention for its steep selloff toward 52-week lows, despite reported contract wins and analyst upgrades. Traders are split between viewing the weakness as an oversold buying opportunity and worrying about valuation, insider selling, and whether production growth can translate into stronger margins and cash flow.

Galaxy Digital, Inc. engages in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. It operates through the following segments: Digital Assets, Data Centers, and Treasury and Corporate. The digital assets segment offers institutional access to trading, advisory, asset management, staking, self-custody, and tokenization technology. The Data Centers segment competes with a range of infrastructure providers that are building or repurposing facilities to support the rapidly growing demand for AI and compute-intensive workloads. The Treasury and Corporate segment includes the company’s proprietary trading and mining activities, as well as the company’s principal investments and related gains and losses. The company was founded by Michael Novogratz in 2018 and is headquartered in New York, NY.

Galaxy Digital Inc. - Ordinary Shares - Class A

GLXY is under pressure amid weakness across crypto and AI/data-center stocks, with traders focused on upcoming earnings and worried about the companys CoreWeave exposure and lack of further tenant news. Sentiment is largely bearish, though some traders see the selloff as overdone and expect earnings or a tenant update to offer support.

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

SHIB is drawing attention for choppy, range-bound trading, with traders debating whether the consolidation will resolve into a rebound or further weakness. Long-term holders are accumulating and hoping for a meme-coin rally, while skeptics point to its stagnant performance, limited utility, and lack of meaningful token burns.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is drawing attention ahead of its Q3 earnings report, with traders debating whether results can halt the stocks slide amid concerns about declining revenue. Crypto-market volatility is another major focus, as many say COIN has fallen with Bitcoin but lagged its rebounds; bullish hopes for an earnings bounce compete with warnings of further downside.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco shares are under pressure after an analyst price-target cut raised concerns about peaking networking growth, despite traders pointing to strong AI-infrastructure demand and recent results. The community is split between treating the pullback as a buying opportunity and seeing the stocks weak, range-bound performance as a sign of lingering growth and valuation concerns.

Corvus Pharmaceuticals, Inc. engages in the development of product candidates for the treatment of cancer and immune-mediated and inflammatory diseases. Its product candidates include soquelitinib, an ITK inhibitor, ciforadenant, an adenosine A2A receptor antagonist, and mupadolimab, a B cell-activating anti-CD73 antibody. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Phase 1 soquelitinib results in atopic dermatitis are driving attention, with traders pointing to promising response signals and broader pipeline potential while debating durability and safety. The share-price drop prompted sell-the-news criticism, with some traders attributing it to short selling, though that remains speculation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Are Industrial Products Stocks Lagging  IDEX (IEX) This Year?

Here is how Idex (IEX) and Murata Manufacturing Inc. (MRAAY) have performed compared to their sector so far this year.

Surging Earnings Estimates Signal Upside for Murata Manufacturing (MRAAY) Stock

Murata Manufacturing Inc. (MRAAY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Is IDEX (IEX) Stock Outpacing Its Industrial Products Peers This Year?

Are Industrial Products Stocks Lagging  Murata Manufacturing (MRAAY) This Year?

Here is how Murata Manufacturing Inc. (MRAAY) and MSC Industrial (MSM) have performed compared to their sector so far this year.

Is Murata Manufacturing (MRAAY) Stock Outpacing Its Industrial Products Peers This Year?

Murata Manufacturing Inc. (MRAAY) is a Great Momentum Stock: Should You Buy?

Does Murata Manufacturing Inc. (MRAAY) have what it takes to be a top stock pick for momentum investors? Let's find out.

Earnings Estimates Moving Higher for Murata Manufacturing (MRAAY): Time to Buy?

Murata Manufacturing (MRAAY) Moves 9.6% Higher: Will This Strength Last?

Murata Manufacturing (MRAAY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Strength Seen in ABB (ABBNY): Can Its 6.0% Jump Turn into More Strength?

ABB (ABBNY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Murata Manufacturing Co., Ltd. engages in research, production and sale of electronic devices made from fine ceramics. It operates through the following segments: Components, Devices and Modules and Others. The Components segment involves in capacitors, inductors, EMI rejection filters, etc. The Devices and Modules segment involves in high-frequency modules, surface wave filters, lithium-ion secondary batteries, sensors, etc. The Others segment involves in healthcare equipment, solutions business, etc. The company was founded by Akira Murata in October 1944 and is headquartered in Nagaokakyo, Japan.

Murata Manufacturing Co. Ltd. - ADR

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$19.84
Prev Close	$20.10
Open	$19.62
Dividend Yield	1.31%
50-Day Moving Average	$23.85
Beta	1.43
Avg. Volume	742,406.10
PE Ratio	42.09

52-Week High	$38.72
52-Week Low	$9.33
Market Capitalization	$72.23B
EPS (Annual)	$0.4236
Price to Book	4.25
Revenue Per Employee	$163,517.13

Feed

News

Sentiment

Earnings

Fundamentals

Info

MRAAY Fundamentals